Literature DB >> 3113982

Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.

F M Filloux, J K Wamsley, T M Dawson.   

Abstract

In vitro receptor autoradiography with [3H]sulpiride (a selective D-2 antagonist) was used to assess the effect of 6-hydroxydopamine and ibotenic acid lesions of the caudate-putamen and substantia nigra pars compacta on D-2 dopamine receptors in rat brain. A marked reduction in [3H]sulpiride binding within the pars compacta of the substantia nigra resulted from lesions of the substantia nigra compacta with either toxin, while substantial reduction in binding within the caudate-putamen followed only ibotenate lesions of that structure. Since (-)sulpiride is a selective D-2 antagonist, these data confirm that autoreceptors on nigral DA neurons are of the D-2 type, while a portion of D-2 receptors in the caudate-putamen are postsynaptic on striatal neurons.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113982     DOI: 10.1016/0014-2999(87)90337-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model.

Authors:  J Wickens
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 2.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

3.  Effect of sulpiride on the amphetamine-induced changes in extracellular dopamine, DOPAC, and hydroxyl radical generation in the rat striatum.

Authors:  Elmira Anderzhanova; Kirill S Rayevsky; Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

4.  Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.

Authors:  J Luthman; E Lindqvist; D Young; R Cowburn
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

5.  Interactions of 7-[3-(4-[2,3-dimethylphenyl]piperazinyl)-propoxy]-2(1H)-quinolinone binding in rat striatum: effects of lesions.

Authors:  X Zhang; Y Nakata; T Kikuchi; T Segawa
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.